SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0000947871-14-000274
Filing Date
2014-04-29
Accepted
2014-04-29 11:31:31
Documents
1
Period of Report
2014-03-31
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 2174
  Complete submission text file 0000947871-14-000274.txt   3213
Mailing Address FREISCHUETZGASSE 3 ZURICH V8 8004
Business Address FREISCHUETZGASSE 3 ZURICH V8 8004 41-61-275-9200
Adamant Biomedical Investments AG (Filer) CIK: 0001542336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 13F-NT | Act: 34 | File No.: 028-14829 | Film No.: 14792148